LONDON ROBERTS: Open Payments
NPI 1558129411 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $240 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $232 |
| GlaxoSmithKline, LLC. | 6 | $102 |
| Optinose US, Inc. | 4 | $63 |
| GENZYME CORPORATION | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Siemens Medical Solutions USA, Inc. | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: DUPIXENT, NUCALA, XHANCE, IMMULITE 1000 Immunoassay System, HYQVIA, KEYTRUDA, CUVITRU.
Industry payments across KY — which companies pay providers there.
